204 related articles for article (PubMed ID: 10579979)
1. Localization of the Wilson's disease protein in human liver.
Schaefer M; Roelofsen H; Wolters H; Hofmann WJ; Müller M; Kuipers F; Stremmel W; Vonk RJ
Gastroenterology; 1999 Dec; 117(6):1380-5. PubMed ID: 10579979
[TBL] [Abstract][Full Text] [Related]
2. Intracellular distribution of the Wilson's disease gene product (ATPase7B) after in vitro and in vivo exogenous expression in hepatocytes from the LEC rat, an animal model of Wilson's disease.
Nagano K; Nakamura K; Urakami KI; Umeyama K; Uchiyama H; Koiwai K; Hattori S; Yamamoto T; Matsuda I; Endo F
Hepatology; 1998 Mar; 27(3):799-807. PubMed ID: 9500710
[TBL] [Abstract][Full Text] [Related]
3. New insights into the pathogenesis of copper toxicosis in Wilson's disease: evidence for copper incorporation and defective canalicular transport of caeruloplasmin.
Chowrimootoo GF; Ahmed HA; Seymour CA
Biochem J; 1996 May; 315 ( Pt 3)(Pt 3):851-5. PubMed ID: 8645167
[TBL] [Abstract][Full Text] [Related]
4. Defective cellular localization of mutant ATP7B in Wilson's disease patients and hepatoma cell lines.
Huster D; Hoppert M; Lutsenko S; Zinke J; Lehmann C; Mössner J; Berr F; Caca K
Gastroenterology; 2003 Feb; 124(2):335-45. PubMed ID: 12557139
[TBL] [Abstract][Full Text] [Related]
5. Hepatocyte-specific localization and copper-dependent trafficking of the Wilson's disease protein in the liver.
Schaefer M; Hopkins RG; Failla ML; Gitlin JD
Am J Physiol; 1999 Mar; 276(3):G639-46. PubMed ID: 10070040
[TBL] [Abstract][Full Text] [Related]
6. Cell therapy to remove excess copper in Wilson's disease.
Gupta S
Ann N Y Acad Sci; 2014 May; 1315(1):70-80. PubMed ID: 24820353
[TBL] [Abstract][Full Text] [Related]
7. Laser ablation inductively coupled plasma mass spectrometry imaging of metals in experimental and clinical Wilson's disease.
Boaru SG; Merle U; Uerlings R; Zimmermann A; Flechtenmacher C; Willheim C; Eder E; Ferenci P; Stremmel W; Weiskirchen R
J Cell Mol Med; 2015 Apr; 19(4):806-14. PubMed ID: 25704483
[TBL] [Abstract][Full Text] [Related]
8. Intracellular localization of the Menkes and Wilson's disease proteins and their role in intracellular copper transport.
Suzuki M; Gitlin JD
Pediatr Int; 1999 Aug; 41(4):436-42. PubMed ID: 10453201
[TBL] [Abstract][Full Text] [Related]
9. The Long-Evans Cinnamon rat: an animal model for Wilson's disease.
Terada K; Sugiyama T
Pediatr Int; 1999 Aug; 41(4):414-8. PubMed ID: 10453197
[TBL] [Abstract][Full Text] [Related]
10. Localization of the Wilson's disease protein product to mitochondria.
Lutsenko S; Cooper MJ
Proc Natl Acad Sci U S A; 1998 May; 95(11):6004-9. PubMed ID: 9600907
[TBL] [Abstract][Full Text] [Related]
11. Wilson's disease.
Loudianos G; Gitlin JD
Semin Liver Dis; 2000; 20(3):353-64. PubMed ID: 11076401
[TBL] [Abstract][Full Text] [Related]
12. Copper-induced apical trafficking of ATP7B in polarized hepatoma cells provides a mechanism for biliary copper excretion.
Roelofsen H; Wolters H; Van Luyn MJ; Miura N; Kuipers F; Vonk RJ
Gastroenterology; 2000 Sep; 119(3):782-93. PubMed ID: 10982773
[TBL] [Abstract][Full Text] [Related]
13. Wilson's disease: a comprehensive review of the molecular mechanisms.
Wu F; Wang J; Pu C; Qiao L; Jiang C
Int J Mol Sci; 2015 Mar; 16(3):6419-31. PubMed ID: 25803104
[TBL] [Abstract][Full Text] [Related]
14. Role of ATP7B in biliary copper excretion in a human hepatoma cell line and normal rat hepatocytes.
Harada M; Sakisaka S; Terada K; Kimura R; Kawaguchi T; Koga H; Taniguchi E; Sasatomi K; Miura N; Suganuma T; Fujita H; Furuta K; Tanikawa K; Sugiyama T; Sata M
Gastroenterology; 2000 May; 118(5):921-8. PubMed ID: 10784591
[TBL] [Abstract][Full Text] [Related]
15. Compound overload of copper and iron in patients with Wilson's disease.
Hayashi H; Yano M; Fujita Y; Wakusawa S
Med Mol Morphol; 2006 Sep; 39(3):121-6. PubMed ID: 16998622
[TBL] [Abstract][Full Text] [Related]
16. Biological functions of ceruloplasmin and their deficiency caused by mutation in genes regulating copper and iron metabolism.
Mzhel'skaya TI
Bull Exp Biol Med; 2000 Aug; 130(8):719-27. PubMed ID: 11177225
[TBL] [Abstract][Full Text] [Related]
17. Long-term metabolic correction of Wilson's disease in a murine model by gene therapy.
Murillo O; Luqui DM; Gazquez C; Martinez-Espartosa D; Navarro-Blasco I; Monreal JI; Guembe L; Moreno-Cermeño A; Corrales FJ; Prieto J; Hernandez-Alcoceba R; Gonzalez-Aseguinolaza G
J Hepatol; 2016 Feb; 64(2):419-426. PubMed ID: 26409215
[TBL] [Abstract][Full Text] [Related]
18. Neurologic Wilson's disease.
Lorincz MT
Ann N Y Acad Sci; 2010 Jan; 1184():173-87. PubMed ID: 20146697
[TBL] [Abstract][Full Text] [Related]
19. [Wilson's disease - a case report].
Karwowska K; Skrzypek J; Chabik G; Członkowska A; Zaborowska M; Wawrzyniak S
Pol Merkur Lekarski; 2016 Jan; 40(235):28-31. PubMed ID: 26891433
[TBL] [Abstract][Full Text] [Related]
20. Rescue of ATP7B function in hepatocyte-like cells from Wilson's disease induced pluripotent stem cells using gene therapy or the chaperone drug curcumin.
Zhang S; Chen S; Li W; Guo X; Zhao P; Xu J; Chen Y; Pan Q; Liu X; Zychlinski D; Lu H; Tortorella MD; Schambach A; Wang Y; Pei D; Esteban MA
Hum Mol Genet; 2011 Aug; 20(16):3176-87. PubMed ID: 21593220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
